Explorez tous les épisodes du podcast IBD Essentials
| Titre | Date | Durée | |
|---|---|---|---|
| Recent BSGE guidelines of chromoendoscopy | 13 May 2026 | 00:20:15 | |
Pradeep Bhandari from Portsmouth (UK) on recent BSGE guidelines of chromoendoscopy, co-hosted by Raf Bisschops. | |||
| Recent clinical trial results informing clinical decision making for vedolizumab and anti-IL23 therapies | 29 Apr 2026 | 00:23:56 | |
Dr. Remo Panaccione, an internationally recognized expert in clinical trials discusses the recent data on vedolizumab and anti-IL23 therapies and how those changes impact clinical decision making in IBD | |||
| Relevance of cell-based therapies in IBD including hematopoetic stem cell transplantation and CAR T cell therapies | 15 Apr 2026 | 00:24:24 | |
Matthieu Allez, Montreal talks about cell-based therapeutic approaches in refractory or complicated IBD covering hematopoetic stem cell transplantation and CAR T cell therapies, indication for this treatment options, success rates and potential side effects and potential future approaches | |||
| Discussion about the role of B cells in health and other autoimmune diseases with highlighting the recent groundbreaking observations of B cell directed CART cell therapy in IBD | 01 Apr 2026 | 00:29:29 | |
Dr. Saurabh Mehandru, Mount Sinai Hospital in New York, internationally recognized physician scientist in IBD and global leader in B cell biology in intestinal health and inflammation discussed the role of B cells in intestinal homeostasis and IBD. Highliy relevant episode about a novel therapy that is entering IBD. | |||
| Introduction of Ailsa Hart as Co-Host of IBD Essentials and Management of Perianal Crohn's disease | 18 Mar 2026 | 00:25:59 | |
Ailsa Hart, St. Marks Hospital, London, UK, internationally renowned IBD expert talks about strategies to optimize the management of perianal fistulising Crohn's disease, relevance of MDT approaches, building international consortia, classification and optimized management of perianal fistulising CD | |||
| Introduction of Florian Rieder as Co-Host of IBD Essentials and Fibrosis in IBD: A new target for evaluation and treatment | 04 Mar 2026 | 00:23:46 | |
Florian Rieder from Cleveland Clinic, Cleveland, USA, internationally renowned IBD and intestinal fibrosis expert talks about his fundamental work and participation in intestinal fibrosis, spanning from basic research, clinical evaluation including establishing a fibrosis PRO, work on international consensus to evaluate intestinal fibrosis and new treatment options for intestinal fibrosis | |||
| How medical guidelines can improve the management of IBD | 18 Feb 2026 | 00:25:58 | |
Andreas Sturm, gastroenterologist and IBDand medical guideline expert from Berlin, discusses about the development of evidence based guidelines and the relevance to improve the management of patients with IBD and the implementation of guidelines into clinical practice. | |||
| Why should students and junior doctors pursue a career in IBD and how can UEG help? | 04 Feb 2026 | 00:22:51 | |
Paulo Sousa from Porto, current chair of the young talent group of UEG, reflects why she decided to become a gastroenterologist and to pursue a career in IBD. She describes how UEG may help tom foster a career in gastroenterology and why it may be useful to engage with UEG beyond UEGW | |||
| Emerging relevance of AI in the management of IBD | 28 Jan 2026 | 00:25:27 | |
Thomas Rösch, editor of Endoscopy Essentials and intgernationally renowned endoscopists discusses the potential role of AI to evaluate and standardize endoscopic disease activity in IBD and the potential repevance of clinical decision support tools to guide clinicians to choose the best treatment options in IBD patients | |||
| Role of nutrition in the etiopathogenesis and treatment of IBD | 07 Jan 2026 | 00:25:57 | |
Iris Dotan, Petah Tikva, Israel, former IOIBD president and international renowned expert in IBD and nutrition, discusses the role of nutrition in the pathogenesis of IBD and the potential of nutritional intervention to treat IBD and to modify the natural course of IBD | |||
| Highlights of new treatment options for IBD from recent phase II and III trials (Abtect, Gladiator, Astro, Graviti), definitions of mild IBD | 19 Dec 2025 | 00:24:26 | |
Silvio Danese, Milan, internationally renowned IBD expert, former ECCO president and UEG Vice president discusses recent data from UEG 2025 on Etrasimod in mild UC (gladiator) and late breaking abstract data on obefazimod in ulcerative colitis | |||
| Meet the Editor Axel Dignass of our new series IBD Essentials | 05 Dec 2025 | 00:27:28 | |
Axel Dignass, internationally renowned IBD expert and editor of the IBD Essentials vodcast, talks about his career and his plans for the podcast, the team, and upcoming topics | |||